A MULTICENTER, OPEN-LABEL EXTENSION STUDY TO EVALUATE THE LONG-TERM SAFETY AND TOLERABILITY OF FARICIMAB IN PATIENTS WITH NEOVASCULAR AGE-RELATED MACULAR DEGENERATION
Research Grant
Administered By
Ophthalmology
Awarded By
Genentech, Inc.
Start Date
February 10, 2021
End Date
December 31, 2024
Administered By
Ophthalmology
Awarded By
Genentech, Inc.
Start Date
February 10, 2021
End Date
December 31, 2024